Webb Michael J. 4
4 · NxStage Medical, Inc. · Filed Jan 4, 2012
Insider Transaction Report
Form 4
Webb Michael J.
SVP, Quality & Regulatory
Transactions
- Tax Payment
Common Stock
2011-12-30$17.78/sh−11,161$198,443→ 15,568 total - Exercise/Conversion
Restricted Stock Unit
2011-12-30−9,339→ 9,338 total→ Common Stock (9,339 underlying) - Sale
Common Stock
2012-01-03$18.15/sh−2,126$38,581→ 13,442 total - Exercise/Conversion
Common Stock
2011-12-30+9,339→ 26,729 total
Footnotes (6)
- [F1]Shares of common stock acquired upon the vesting of restricted stock units.
- [F2]This transaction reflects the withholding of shares of the Company's common stock to satisfy the reporting person's tax liability incurred in connection with the final tranche of awards granted to the reporting person on March 3, 2010 pursuant to the Company's 2009 Performance Share Plan, and the vesting of the second tranche of awards granted to the reporting person on March 8, 2011 pursuant to the Company's 2010 Performance Share Plan.
- [F3]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 19,2011.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.40. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F5]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock
- [F6]In March 2010, the Compensation Committee established the Company's 2010 Performance Share Plan with the amount of awards to be determined based upon the satisfaction of 2010 revenue and cash consumption targets. On March 8, 2011, the Compensation Committee granted the reporting person 28,016 restricted stock units based on its evaluation of the achievement of performance criteria under the Company's 2010 Performance Share Plan. The award vested 33 1/3rd% on the date of grant (March 8, 2011), with the balance vesting in two equal installments on December 31, 2011 and December 31, 2012.